Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
196.56B
Market cap196.56B
Price-Earnings ratio
11.40
Price-Earnings ratio11.40
Dividend yield
4.04%
Dividend yield4.04%
Average volume
13.46M
Average volume13.46M
High today
$80.70
High today$80.70
Low today
$77.91
Low today$77.91
Open price
$80.28
Open price$80.28
Volume
14.04M
Volume14.04M
52 Week high
$134.63
52 Week high$134.63
52 Week low
$73.31
52 Week low$73.31

MRK News

Simply Wall St 6d
Here's What We Like About Merck's Upcoming Dividend

Merck & Co., Inc. ( ) is about to trade ex-dividend in the next three days. The ex-dividend date is one business day before the record date, which is the cut-of...

Here's What We Like About Merck's Upcoming Dividend
Seeking Alpha 6d
RFK Jr’s new vaccine advisor has reportedly served as expert witness against Merck vaccine

One of the new members that Health Secretary Robert F. Kennedy Jr. has picked for the CDC’s vaccine advisory panel has served as an expert witness in a major li...

RFK Jr’s new vaccine advisor has reportedly served as expert witness against Merck vaccine
Seeking Alpha 7d
Merck rival Summit draws a rare sell-equivalent rating

Shares of Summit Therapeutics (NASDAQ:SMMT) ended four straight sessions of gains on Wednesday after Leerink Partners initiated its coverage with a Sell-equival...

Merck rival Summit draws a rare sell-equivalent rating

Analyst ratings

62%

of 26 ratings
Buy
61.5%
Hold
38.5%
Sell
0%

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.